These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3284451)

  • 21. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of inotropic agents in the treatment of cardiac insufficiency].
    Coma Canella I; López-Sendón J
    Rev Esp Cardiol; 1984; 37(3):186-95. PubMed ID: 6150525
    [No Abstract]   [Full Text] [Related]  

  • 23. Inotropes in the management of acute heart failure.
    Petersen JW; Felker GM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug treatment of left ventricular insufficiency. Current aspects].
    Jaeger P; Cohen Solal A; Dahan M; Juliard JM; Charlier P; Gourgon R
    Rev Mal Respir; 1987; 4(6):287-94. PubMed ID: 3327120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New inotropic agents in the treatment of congestive heart failure].
    Hutton I; McKillop J; Clark R; Martin W; Tweddel A
    Ter Arkh; 1982; 54(11):98-101. PubMed ID: 7157176
    [No Abstract]   [Full Text] [Related]  

  • 26. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M; De Luca L; Massie MB; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?].
    Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A
    Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New drugs with positive inotropic action].
    Bijak A; Czołpiński T
    Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
    [No Abstract]   [Full Text] [Related]  

  • 29. An overview of inotropic agents.
    Vroom MB
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):246-52. PubMed ID: 16959760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value and limitations of new cardiotonic agents].
    Grosgogeat Y; Komajda M
    Bull Acad Natl Med; 1989 Feb; 173(2):121-30; discussion 131. PubMed ID: 2670075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Phytogenic drugs in heart diseases exemplified by Crataegus].
    Loew D
    Wien Med Wochenschr; 1999; 149(8-10):226-8. PubMed ID: 10483686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction in mortality by pharmacological therapy in congestive heart failure.
    Swedberg K
    Circulation; 1993 May; 87(5 Suppl):IV126-9. PubMed ID: 8485828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation.
    Teramura S; Yamakado T
    Cardiologia; 1998 Apr; 43(4):375-85. PubMed ID: 9659795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current role of non-digitalis inotropic agents in acute and chronic treatment of heart failure].
    Dei Cas L; Nodari S; Raddino R; Metra M; Pelà G; Nardi M
    Cardiologia; 1994 Mar; 39(3):209-15. PubMed ID: 8039201
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of heart failure. I. Definition, pathophysiology, therapy of acute heart failure].
    Schwinger RH; Erdmann E
    Fortschr Med; 1997 Jun; 115(16):30-4. PubMed ID: 9280746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study.
    Rossinen J; Harjola VP; Siirila-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS
    Acute Card Care; 2008; 10(4):209-13. PubMed ID: 18720087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of resistant cardiac failure; vasodilators and new inotropic drugs].
    Herziano H; Gil I; Almog C
    Harefuah; 1980 Jun; 98(11-12):517-8. PubMed ID: 7203196
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.